[The use of a beta-blocker esmolol in patients with acute myocardial infarction treated with streptokinase]

Kardiologiia. 2002;42(6):4-7.
[Article in Russian]

Abstract

Infusion of esmolol (50-300 mcg/kg/min, mean 119-/+75.5 mcg/kg/min, average duration 3.2-/+1.22 h)) was carried out in 49 streptokinase treated patients within 6 hours of myocardial infarction. Infusion was associated with slowing of heart rate and lowering of mean dynamic systolic blood pressure (by 22%). No changes of stroke volume and index occurred. Complications requiring either cessation of infusion or decrease of its rate developed in 14.3% of patients (lowering of systolic blood pressure below 100 mm Hg in 5, complete atrio-ventricular block in 2) as a rule in the beginning of the infusion.

Publication types

  • Clinical Trial
  • English Abstract

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Adult
  • Aged
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / drug therapy*
  • Plasminogen Activators / therapeutic use*
  • Propanolamines / therapeutic use*

Substances

  • Adrenergic beta-Antagonists
  • Propanolamines
  • Plasminogen Activators
  • esmolol